Article Details

Insmed Incorporated (NASDAQ:INSM) Receives Average Rating of "Buy" from Analysts

Retrieved on: 2021-01-02 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

Insmed Incorporated (NASDAQ:INSM) Receives Average Rating of "Buy" from Analysts. View article details on hiswai:

Excerpt

Morgan Stanley raised their target price on Insmed from $42.00 to $55.00 and gave the company an "overweight" rating in a research report on ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo